214 related articles for article (PubMed ID: 8521686)
1. Red blood cell transfusion practices in the neonate.
Strauss RG
Clin Perinatol; 1995 Sep; 22(3):641-55. PubMed ID: 8521686
[TBL] [Abstract][Full Text] [Related]
2. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin.
Strauss RG
Transfus Med Rev; 2001 Jul; 15(3):213-23. PubMed ID: 11471123
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with red blood cell transfusions in very-low-birth-weight preterm infants in Brazilian neonatal units.
dos Santos AM; Guinsburg R; de Almeida MF; Procianoy RS; Marba ST; Ferri WA; Rugolo LM; Lopes JM; Moreira ME; Luz JH; González MR; Meneses Jdo A; da Silva RV; Abdallah VO; Duarte JL; Marques PF; Rego MA; Alves Filho N; Krebs VL;
BMC Pediatr; 2015 Sep; 15():113. PubMed ID: 26341125
[TBL] [Abstract][Full Text] [Related]
4. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era.
Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K
Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976
[TBL] [Abstract][Full Text] [Related]
5. A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity.
Fain J; Hilsenrath P; Widness JA; Strauss RG; Mutnick AH
Transfusion; 1995; 35(11):936-43. PubMed ID: 8604492
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic growth factors: Part II.
Wandstrat TL; Wolfe M
Neonatal Netw; 1996 Oct; 15(7):25-8. PubMed ID: 9035641
[TBL] [Abstract][Full Text] [Related]
7. Current controversies in the management of the anemia of prematurity.
Bishara N; Ohls RK
Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
[TBL] [Abstract][Full Text] [Related]
8. Red Blood Cell Transfusion Thresholds for Anemia of Prematurity.
Holzapfel LF; Rysavy MA; Bell EF
Neoreviews; 2023 Jun; 24(6):e370-e376. PubMed ID: 37258497
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
10. Neonatal anemia.
Aher S; Malwatkar K; Kadam S
Semin Fetal Neonatal Med; 2008 Aug; 13(4):239-47. PubMed ID: 18411074
[TBL] [Abstract][Full Text] [Related]
11. Neonatal anemia: pathophysiology and treatment.
Strauss RG
Immunol Invest; 1995; 24(1-2):341-51. PubMed ID: 7713595
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of transfusion in anemia of very low birth weight infants.
Jeon GW; Sin JB
Yonsei Med J; 2013 Mar; 54(2):366-73. PubMed ID: 23364969
[TBL] [Abstract][Full Text] [Related]
13. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
Dallman PR
Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
[No Abstract] [Full Text] [Related]
14. Erythropoietin--not yet a standard treatment for anemia of prematurity.
Wilimas JA; Crist WM
Pediatrics; 1995 Jan; 95(1):9-10. PubMed ID: 7770317
[No Abstract] [Full Text] [Related]
15. Anaemia of prematurity: pathophysiology and treatment.
Strauss RG
Blood Rev; 2010 Nov; 24(6):221-5. PubMed ID: 20817366
[TBL] [Abstract][Full Text] [Related]
16. Effects of blood sampling stewardship and erythropoietin administration in extremely low birth weight infants-a quality improvement non-controlled before-and-after retrospective study.
Balasubramanian H; Atyalgade M; Garg B; Srinivasan L; Kabra NS; Khapekar S
Eur J Pediatr; 2021 May; 180(5):1617-1626. PubMed ID: 33464366
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
18. Potential for treatment of anemia of prematurity with recombinant human erythropoietin.
Phibbs RH
Curr Opin Pediatr; 1995 Apr; 7(2):140-5. PubMed ID: 7787927
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.
Shireman TI; Hilsenrath PE; Strauss RG; Widness JA; Mutnick AH
Arch Pediatr Adolesc Med; 1994 Jun; 148(6):582-8. PubMed ID: 8193681
[TBL] [Abstract][Full Text] [Related]
20. [Anemia of prematurity: risk factors influencing red cell transfusions].
Zuppa AA; Mazzotta M; Maragliano G; Girlando P; Florio MG; Tortorolo G
Minerva Pediatr; 1995; 47(1-2):13-8. PubMed ID: 7791703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
